Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Aripiprazole for Weight in Schizophrenia
NCT00300846Phase 4Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Dec 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Aripiprazole + Clozapine with Placebo + Clozapine (2 arms). Primary endpoint: Mean change from baseline in patient weight at 16 weeks. Started Dec 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00300846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300846.